Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 4
2021 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Growth Differentiation Factor 15 Is Superior to Troponin I in the Evaluation of Kidney Transplant Candidates.
de Cos Gomez M, Garcia Unzueta MT, Benito Hernandez A, Aguilera Fernandez A, Perez Arnedo M, Lopez Del Moral Cuesta C, Kislikova M, Valero San Cecilio R, Ruiz San Millan JC, Rodrigo Calabia E. de Cos Gomez M, et al. Among authors: lopez del moral cuesta c. Am J Nephrol. 2022;53(2-3):118-128. doi: 10.1159/000521781. Epub 2022 Feb 23. Am J Nephrol. 2022. PMID: 35196660
Immunosuppression with Calcineurin Inhibitor after Renal Transplant Failure Inhibits Allosensitization.
López Del Moral Cuesta C, Guiral Foz S, Gómez Pereda D, Pérez Canga JL, de Cos Gómez M, Mazón Ruiz J, García Santiago A, Romón Alonso JI, Valero San Cecilio R, Rodrigo Calabia E, San Segundo Arribas D, López Hoyos M, Ruiz San Millán JC. López Del Moral Cuesta C, et al. Biomedicines. 2020 Mar 28;8(4):72. doi: 10.3390/biomedicines8040072. Biomedicines. 2020. PMID: 32231087 Free PMC article.
Clinical experience with tolvaptan in patients with polycystic kidney disease.
López Del Moral Cuesta C, Fernández Fresnedo G, Martín Penagos L. López Del Moral Cuesta C, et al. Med Clin (Barc). 2020 Jul 24;155(2):83-84. doi: 10.1016/j.medcli.2019.03.011. Epub 2019 May 23. Med Clin (Barc). 2020. PMID: 31130311 English, Spanish. No abstract available.
Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.
Martín-Penagos L, Benito A, Oviedo MV, López Del Moral Cuesta C, Martín López J, Gómez Román J, López-Mejías R, Fernandez-Fresnedo G, Ruíz San Millán JC, Rodrigo Calabia E. Martín-Penagos L, et al. Among authors: lopez del moral cuesta c. Nefrologia (Engl Ed). 2019 Sep-Oct;39(5):523-530. doi: 10.1016/j.nefro.2018.10.015. Epub 2019 Mar 20. Nefrologia (Engl Ed). 2019. PMID: 30902505 Free article. English, Spanish.
Growth Differentiation Factor 15: A Biomarker with High Clinical Potential in the Evaluation of Kidney Transplant Candidates.
de Cos Gomez M, Benito Hernandez A, Garcia Unzueta MT, Mazon Ruiz J, Lopez Del Moral Cuesta C, Perez Canga JL, San Segundo Arribas D, Valero San Cecilio R, Ruiz San Millan JC, Rodrigo Calabia E. de Cos Gomez M, et al. Among authors: lopez del moral cuesta c. J Clin Med. 2020 Dec 20;9(12):4112. doi: 10.3390/jcm9124112. J Clin Med. 2020. PMID: 33419237 Free PMC article.
Low-risk delisting strategy in highly sensitized patients without donor offers included in exchange donation programs. One single-center experience.
Comins-Boo A, Irure-Ventura J, Valentin MO, Belmar-Vega L, López Del Moral Cuesta C, Valero San Cecilio R, Rodrigo Calabia E, Renuncio-García M, Castro Hernández C, Mikhalkovich D, Mota Pérez N, Ruiz San Millán JC, López-Hoyos M, San Segundo D. Comins-Boo A, et al. Among authors: lopez del moral cuesta c. Hum Immunol. 2024 Apr 24:110806. doi: 10.1016/j.humimm.2024.110806. Online ahead of print. Hum Immunol. 2024. PMID: 38664156